CVS Health Corporation (NYSE:CVS) Stock Has Average Price Target of $107.24 According to Brokerages

Shares of CVS Health Corporation (NYSE:CVS) have received an average recommendation of “Moderate Buy” from the twenty-three analysts that are covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold recommendation and twenty-two have assigned a buy recommendation to the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $107.24.

CVS has been the subject of a number of recent research reports. Royal Bank Of Canada lifted their price objective on CVS Health from $107.00 to $113.00 and gave the stock an “outperform” rating in a research report on Thursday, July 9th. JPMorgan Chase & Co. lifted their price objective on CVS Health from $111.00 to $118.00 and gave the company an “overweight” rating in a research note on Wednesday, August 12th. Wall Street Zen cut CVS Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, October 3rd. BMO Capital Markets set a $112.00 target price on CVS Health in a research report on Wednesday, September 9th. Finally, Barclays upped their price target on shares of CVS Health from $106.00 to $108.00 and gave the company an “overweight” rating in a report on Thursday, August 6th.

Institutional Investors Weigh In On CVS Health

Hedge funds have recently added to or reduced their stakes in the stock. Kilter Group LLC acquired a new position in shares of CVS Health during the second quarter worth approximately $27,000. Beaird Harris Wealth Management LLC increased its stake in CVS Health by 201.0% in the 2nd quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock worth $30,000 after purchasing an additional 195 shares in the last quarter. J.Safra Asset Management Corp purchased a new stake in shares of CVS Health in the second quarter valued at $30,000. Timbuktu Capital Management LLC purchased a new stake in CVS Health in the 2nd quarter worth about $31,000. Finally, Dunhill Financial LLC acquired a new stake in shares of CVS Health during the second quarter worth approximately $32,000. 80.66% of the stock is currently owned by institutional investors.

CVS Health Stock Down 0.0%

CVS opened at $87.91 on Tuesday. The company has a market cap of $112.43 billion, a price-to-earnings ratio of 23.26, a PEG ratio of 0.82 and a beta of 0.60. CVS Health has a one year low of $69.51 and a one year high of $110.68. The business’s fifty day moving average is $93.10 and its two-hundred day moving average is $92.41. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, beating the consensus estimate of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The firm had revenue of $106.10 billion during the quarter, compared to the consensus estimate of $100.03 billion. During the same period last year, the firm posted $1.81 EPS. The firm’s revenue for the quarter was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Analysts anticipate that CVS Health will post 8.02 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 2nd. Investors of record on Thursday, October 22nd will be paid a dividend of $0.6650 per share. The ex-dividend date is Thursday, October 22nd. This represents a $2.66 annualized dividend and a yield of 3.0%. CVS Health’s dividend payout ratio is 70.37%.

CVS Health News Summary

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Aetna’s Medicare Advantage quality ratings provide a potential tailwind. CVS said more than 69% of Aetna Medicare Advantage members will be enrolled in plans rated four stars or higher for 2027. Strong CMS ratings can support member retention, enrollment and bonus payments, while reinforcing Aetna’s recovering margins. Aetna 2027 Star Ratings Reflect Strong Clinical Quality and Member Experience
• Positive Sentiment: Analysts point to several potential growth drivers. CVS trades at a discount to healthcare peers, while Aetna margins are recovering, pharmacy trends are improving and the Health Services segment is gaining momentum. These factors support the view that the stock may be undervalued if the turnaround continues. CVS Health Trades at a Discount to Industry
• Positive Sentiment: Long-term drug distribution agreements improve supply-chain certainty. CVS extended its pharmaceutical distribution contracts with Cardinal Health and McKesson through 2032, supporting reliable nationwide distribution for its retail pharmacies and other dispensing channels. CVS Extends Drug Distribution Deals to 2032
• Neutral Sentiment: CVS is expanding targeted pharmacy access. The company opened its first pharmacy-focused location in the Boston area, a smaller-format model intended to improve medication, vaccination and pharmacist-service access. The initiative may strengthen community presence but is unlikely to materially affect near-term earnings. CVS Opens Pharmacy-Focused Boston Location
• Neutral Sentiment: Unusual options activity signals increased trading interest, not necessarily a fundamental change. Traders purchased approximately 23,271 CVS call options, about 33% above typical volume.
• Negative Sentiment: 340B reimbursement pressures remain a risk. Despite the improving outlook for Aetna and pharmacy operations, continuing 340B headwinds could limit margins and delay the company’s broader earnings recovery. CVS Health Trades at a Discount to Industry

CVS Health Company Profile

CVS Health Corp. is an integrated health care company that provides pharmacy, insurance and health services primarily in the United States. Its operations are designed to connect consumers, health plans, health care providers and pharmacy services across multiple points of care.

The company’s major businesses include CVS Pharmacy retail locations, prescription fulfillment and consumer health products; CVS Caremark, a pharmacy benefit management business; and Aetna, which offers health insurance products and related services for employers, individuals, government programs and other organizations.